pramipexole has been researched along with 3,3'-dihexyl-2,2'-oxacarbocyanine in 1 studies
Studies (pramipexole) | Trials (pramipexole) | Recent Studies (post-2010) (pramipexole) | Studies (3,3'-dihexyl-2,2'-oxacarbocyanine) | Trials (3,3'-dihexyl-2,2'-oxacarbocyanine) | Recent Studies (post-2010) (3,3'-dihexyl-2,2'-oxacarbocyanine) |
---|---|---|---|---|---|
1,103 | 219 | 517 | 143 | 0 | 16 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cooper, JM; Gu, M; Iravani, MM; Irvani, M; Jenner, P; King, D; Schapira, AH | 1 |
1 other study(ies) available for pramipexole and 3,3'-dihexyl-2,2'-oxacarbocyanine
Article | Year |
---|---|
Pramipexole protects against apoptotic cell death by non-dopaminergic mechanisms.
Topics: 1-Methyl-4-phenylpyridinium; Aconitate Hydratase; Antioxidants; Benzothiazoles; Carbocyanines; Caspase 3; Caspases; Cell Count; Cell Death; Cell Line, Tumor; Cell Survival; Cytochromes c; Dose-Response Relationship, Drug; Drug Interactions; Flow Cytometry; Humans; Jurkat Cells; L-Lactate Dehydrogenase; Mitochondria; Necrosis; Neuroblastoma; Pramipexole; Rotenone; Thiazoles | 2004 |